Becton Dickinson Net Worth 2010-2023 | BDX

Interactive chart of historical net worth (market cap) for Becton Dickinson (BDX) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Becton Dickinson net worth as of December 07, 2023 is $67.82B.
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $67.821B $19.372B
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $60.631B 16.51
Cardinal Health (CAH) United States $26.219B 16.78
West Pharmaceutical Services (WST) United States $25.245B 42.54
Labcorp (LH) United States $18.477B 14.74
Cooper (COO) United States $17.083B 26.95
Align Technology (ALGN) United States $16.590B 36.34
Henry Schein (HSIC) United States $9.296B 14.17
DENTSPLY SIRONA (XRAY) United States $6.881B 17.56
Merit Medical Systems (MMSI) United States $4.020B 23.28
CONMED (CNMD) United States $3.370B 39.00
Patterson (PDCO) United States $2.443B 11.17
STAAR Surgical (STAA) United States $1.529B 69.60
Atrion (ATRI) United States $0.575B 27.07
Lifevantage (LFVN) United States $0.084B 21.42
Pro-Dex (PDEX) United States $0.057B 18.98
Biolase (BIOL) United States $0.003B 0.00